Sanofi slams judge’s harm assessment in denying injector pen injunction

Intellectual Property 2019-02-08 9:39 pm By Miklos Bolza | Sydney

A judge that rejected a bid by Sanofi-Aventis for an injunction blocking rival Alphapharm from listing an insulin injector pen on the PBS erred in his consideration of the harm it would face, the drug giant has told the Full Federal Court.